{
    "organizations": [],
    "uuid": "bc04a661e63f808f39ff1b06f2ffa478416ac2e6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cytokinetics-announces-progress-ag/brief-cytokinetics-announces-progress-against-vision-2020-idUSFWN1OY0EF",
    "ord_in_thread": 0,
    "title": "BRIEF-Cytokinetics Announces Progress Against Vision 2020",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 3, 2018 / 12:32 PM / in 6 minutes BRIEF-Cytokinetics Announces Progress Against Vision 2020 Reuters Staff \nJan 3 (Reuters) - Cytokinetics Inc: * CYTOKINETICS ANNOUNCES PROGRESS AGAINST VISION 2020 \n* CYTOKINETICS INC - ‍RESULTS FROM FOUR CLINICAL TRIALS OF CK-2127107 EXPECTED IN 2018​ \n* CYTOKINETICS INC - RESULTS FROM FOUR CLINICAL TRIALS OF CK-2127107 EXPECTED IN 2018 \n* CYTOKINETICS INC - ‍ENROLLMENT OF PATIENTS IN GALACTIC-HF IS ON TRACK IN 2018​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T14:31:00.000+02:00",
    "crawled": "2018-01-03T14:47:32.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "announces",
        "progress",
        "vision",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "cytokinetics",
        "inc",
        "cytokinetics",
        "announces",
        "progress",
        "vision",
        "cytokinetics",
        "inc",
        "four",
        "clinical",
        "trial",
        "expected",
        "cytokinetics",
        "inc",
        "result",
        "four",
        "clinical",
        "trial",
        "expected",
        "cytokinetics",
        "inc",
        "patient",
        "track",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}